Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

LGVN stock hub

Longeveron Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

LGVNis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

24.7M

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

LGVN

In the news

Latest news · LGVN

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROE-164.7

P25 -105.6P50 -46.5P75 -3.1

ROIC-97.6

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All LGVN market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

208

Groups with data

Currency

USD

Showing 208 of 208 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001721484
Company name	Longeveron Inc.
Country	United States
Country code	US
Cusip	54303L104
Employees	38
Employees Change	12%
Employees Change Percent	46.15
Enterprise value	$20.9M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
IPO Date	2021-02-12
Isin	US54303L2034
Last refreshed	2026-05-10
Market cap	$24.7M
Market cap category	Nano-Cap
Price	$0.85
Price currency	USD
Rev Per Employee	31,552.63x
Sector	Healthcare
Sic	2834
Symbol	LGVN
Website	https://longeveron.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-91.74%
EV Sales Forward	14.82x
EV/Sales	17.44x
FCF yield	-76.33%
P/B ratio	3.41x
P/S ratio	20.64x
PS Forward	17.54x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross margin	66.97%
Gross Profit	$803,000
Gross Profit Growth	-57.38%
Gross Profit Growth Q	-51.51%
Gross Profit Growth3 Y	17.34%
Gross Profit Growth5 Y	-15.15%
Net Income	$-22.7M
Net Income Growth Years	1%
Pretax Margin	-1,893.58%
Profit Per Employee	$-597,474
ROA	-81.27
Roa5y	-55.21
ROCE	-377.2
ROE	-164.7
Roe5y	-117
ROIC	-97.57

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-43.3%
Cagr3y	-69.86%
Cagr5y	-56.76%
EPS Growth Years	2
Revenue Growth	-49.88x
Revenue Growth Q	-39.47x
Revenue Growth Years	0x
Revenue Growth3 Y	-0.63x
Revenue Growth5 Y	-26.6x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.07
Assets	$10.3M
Cash	$4.7M
Current Assets	$5.5M
Current Liabilities	$4.1M
Debt	$824,000
Debt Equity	$0.15
Equity	$5.7M
Liabilities	$4.6M
Long Term Assets	$4.8M
Long Term Liabilities	$499,000
Net Cash	$3.8M
Net Cash By Market Cap	$15.5
Net Cash Growth	-78.43%
Net Debt Equity	$-0.68
Tangible Book Value	$3.4M
Tangible Book Value Per Share	$0.15
WACC	2.4

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.33
Net Working Capital	$-2.6M
Quick ratio	1.17
Working Capital	$1.4M
Working Capital Turnover	$0.13

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-86.76%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-43.28%
200-day SMA	0.79
3Y total return	-97.26%
50-day SMA	0.92
50-day SMA vs 200-day SMA	50over200
5Y total return	-98.49%
All Time High	450
All Time High Change	-99.81%
All Time High Date	2021-11-24
All Time Low	0.48
All Time Low Change	77.94%
All Time Low Date	2026-03-06
ATR	0.07
Beta	-0.32
Beta1y	-0.31
Beta2y	1.56
Ch YTD	67.04
High	0.88
High52	1.8
High52 Date	2025-07-21
High52ch	-53.04%
Low	0.84
Low52	0.48
Low52 Date	2026-03-06
Low52ch	77.94%
Ma50ch	-7.77%
Premarket Change Percent	-0.2
Premarket Price	$0.85
Premarket Volume	3,076
Price vs 200-day SMA	6.49%
RSI	37.95
RSI Monthly	37.7
RSI Weekly	50.87
Sharpe ratio	0.05x
Sortino ratio	0.14
Total Return	-86.76%
Tr YTD	67.04
Tr1m	-27.14%
Tr1w	-0.68%
Tr3m	64.76%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	2
Analyst Count Top	1
Analyst Price Target Top	$3
Analyst Ratings	Strong Buy
Analyst Ratings Top	Strong Buy
Earnings EPS Estimate	$-0.19
Earnings Revenue Estimate	333,200x
Earnings Revenue Estimate Growth	-12.55x
Operating Income	$-23.3M
Operating margin	-1,942.2
Price target	$5.5
Price Target Change	$551
Price Target Change Top	$255

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	24,938,499%
Float Percent	85.17%
Shares Insiders	14.73%
Shares Institutions	5.85%
Shares Out	29,281,138
Shares Qo Q	19.37%
Shares Yo Y	86.76%
Short Float	11.65%
Short Ratio	1.22
Short Shares	9.92

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-20.6M
Average Volume	499,536.45x
Bv Per Share	0.25
CAPEX	$-245,000
Ch1m	-27.14
Ch1w	-0.68
Ch1y	-43.28
Ch3m	64.76
Ch3y	-97.26
Ch5y	-98.49
Ch6m	14.68
Change	-0.77%
Change From Open	-2.82
Close	0.85
Days Gap	2.1
Depreciation Amortization	1,226,000
Dollar Volume	394,548.7
Earnings Date	2026-05-13
Earnings Time	amc
EBIT	$-23.3M
EBITDA	$-22.1M
EPS	$-1.29
F Score	1
FCF	$-18.9M
FCF EV Yield	-90.33x
FCF Per Share	$-0.65
Financing CF	4,669,000
Fiscal Year End	December
Founded	2,014
Investing CF	-595,000
Ipr	-91.55
Iprfo	-99.15
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-03-17
Last Report Date	2025-12-31
Last Split Date	2024-03-27
Last Split Type	Reverse
Last10k Filing Date	2026-03-17
Ma150	0.74
Ma150ch	14.45%
Ma20	0.96
Ma20ch	-12%
Net CF	-14,571,000
Next Earnings Date	2026-05-13
Open	0.87
Optionable	No
Position In Range	11.31
Post Close	0.85
Postmarket Change Percent	-1.15
Postmarket Price	$0.84
Ppne	2,349,000
Pre Close	0.85
Price Date	2026-05-08
Ptbv Ratio	7.3
Relative Volume	0.93x
Revenue	1,199,000x
SBC By Revenue	139.87x
Share Based Comp	1,677,000
Tr6m	14.68%
Us State	Florida
Volume	466,811
Z Score	-22.75

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does LGVN pay a dividend?

Capital-return profile for this ticker.

Performance

LGVN stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns LGVN?

Insider, institutional, and short-interest positioning.

Institutional ownership

+5.8%

Float: +85.2% of shares outstanding

Insider ownership

+14.7%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

LGVN momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

38.0

Neutral momentum band

Price vs 200-day MA

+6.5%

50/200-day relationship not available

Beta (5Y)

-0.32

Less volatile than the market

Sharpe ratio

0.05

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About LGVN

Hub-level FAQ points readers to the deeper analysis pages.

What is the current LGVN stock rating?

Longeveron Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full LGVN analysis?

The full report lives at /stocks/LGVN/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for LGVN?

The latest report frames LGVN around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the LGVN page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.